Upon targeted deep sequencing, significant mutations in the S1 tumor involved KRAS, while the significant mutations in the S6 tumor involved TP53, MAP2K1 and FOXP2 (Table 2 and Figure 1). The gene discussed is KRAS; the disease is neoplasm.